Haloperidol
NDC Package 76237-260-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Haloperidol is used to treat certain mental/mood disorders (e.g., schizophrenia, schizoaffective disorders). Marketed by Mckesson Contract Packaging, this product is identified by NDC 76237-260 and is authorized under FDA application ANDA070278.

Identification & Billing

NDC Package Code
76237-260-30
Package Description
6 BLISTER PACK in 1 BOX, UNIT-DOSE / 5 TABLET in 1 BLISTER PACK
Product Code
76237-260
11-Digit Billing Format
76237026030

Clinical Specifications

Proprietary Name
Haloperidol
Dosage Form
-
Usage Information
Haloperidol is used to treat certain mental/mood disorders (e.g., schizophrenia, schizoaffective disorders). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also help prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations. Haloperidol can also be used to treat uncontrolled movements and outbursts of words/sounds related to Tourette's syndrome. Haloperidol is also used for severe behavior problems in hyperactive children when other treatments or medications have not worked. Haloperidol is a psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances in the brain (neurotransmitters).

Regulatory & Marketing

Labeler Name
Mckesson Contract Packaging
FDA Application #
ANDA070278
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-10-1986
End Marketing Date
09-30-2017
Listing Expiration
09-30-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76237-260-30 identifies a specific commercial package of 6 blister pack in 1 box, unit-dose / 5 tablet in 1 blister pack of Haloperidol, labeled by Mckesson Contract Packaging. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson Contract Packaging on June 10, 1986. The current certification is valid through September 30, 2017.

What are the primary indications for this medication?

Haloperidol is used to treat certain mental/mood disorders (e.g., schizophrenia, schizoaffective disorders). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also help prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations. Haloperidol can also be used to treat uncontrolled movements and outbursts of words/sounds related to Tourette's syndrome. Haloperidol is also used for severe behavior problems in hyperactive children when other treatments or medications have not worked. Haloperidol is a psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances in the brain (neurotransmitters).

How is this Mckesson Contract Packaging product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76237026030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76237-260-30
11-Digit CMS (5-4-2)
76237-0260-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.